Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACER established rheumatoid arthritis biologic response prediction study
NL-OMON39156Active, not recruiting
- Sponsor
- Centre for Translational Molecular Medicine
- Start
- Feb 2014
- Countries
- 1
01
Overview
Open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by Centre for Translational Molecular Medicine. Primary endpoints: Clinical response to biologic treatment, Prediction of response by ACPA profiling and 2 more. Started Feb 2014; status: active, not recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON39156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39156.